Stock Symbol:

DNDN

Company Name:

Dendreon Corporation

Company Description:

Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. The company offers active cellular immunotherapy, monoclonal antibody, and small molecule product candidates to treat various cancers.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

J-A-J-O

Stock Exchange:

NASDAQ

Predicted Split Price:

$59.00

Predicted Split Ratio:

2 for 1

5 Day Performance After Split:

3.6%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.